Tải xuống
Tóm tắt
ABSTRACT
Background: Immune thrombocytopenia (ITP) is the most common of the hemorrhagic diseases caused by thrombocytopenia in children. It usually occurs between the ages of 5 and 7 years old and at both sexes. It is difficult to predict ITP basing on bleeding because some severe thrombocytopenia cases have slight purpura or ecchymoses. This study aims to describe the clinical and hematological features of childhood immune thrombocytopenia
Methods: This was a cross - sectional study. Patients were stratified according to age (0 to 15 years) and diagnosed ITP at the Pediatric Center of Hue central Hospital.
Results: From May 2020 to March 2021, we identified 42 children diagnosed with idiopathic thrombocytopenia. Newly diagnosed ITP was the most common (66.7%) followed by chronic ITP (26.2%) and persistent ITP (7.1%). There was a slight predominance of boys to girls with the male - to - female ratio was 2:1. However, this ratio was dependent on ITP phases. The highest prevalence of immune
thrombocytopenia was found under 6 years old. Children in this study usually had a history of preceding infection or vaccination. Natural hemorrhage was 83.3% (skin 95.2%). The most common type of cutaneous bleeding was petechiae (83.3%). Mild to moderate hemorrhages were dominant. Newly diagnosed ITP had less severity of hemorrhage than persistent and chronic ITP. Most children did not have a fever, hepatomegaly, splenomegaly, and lymphadenopathy. The majority of children seem to have severe thrombopenia (66.7%), but the number of platelets was not related to the severity of bleeding. Mean platelet volume was normal.
Conclusions: Newly diagnosed ITP was the most common. There was a little clinical and hematological features difference between the ITP phases.
Tài liệu tham khảo
Wilson DB, Acquired Platelet Defects, in Nathan and Oski’s hematology and oncology of infancy and childhood, 8 edition. 2015, Elsevier
Saunders: Philadelphia, PA 19103-2899. p. pp. 1076-1102.
Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009 113: pp. 2386-2393.
Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. American Journal of Hematology. 2010. 85: pp. 174-180.
Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood advances. 2019. 3: pp. 3829-3866.
Neunert C, Noroozi N, Norman G, Buchanan GR, Goy J, Nazi I, et al. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. Journal of Thrombosis and Haemostasis. 2015. 13: pp. 457-464.
Neunert CE, Buchanan GR, Imbach P, BoltonMaggs PHB, Bennett CM, Ellis J Neufeld, et al. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood. 2008. 112: pp. 4003-4011.
Kuter DJ, Mathias SD, Rummel M, Mandanas R, Giagounidis AA, Xuena Wang, et al. Healthrelated quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care. American Journal of Hematology. 2012. 87: pp.
-561.
Snyder CF, Mathias SD, Cella D, Isitt JJ, Wu AW, Young J. Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey. Current Medical Research and Opinion. 2008. 24: pp. 2767-2776.
Aerts E, Derbyshire L, Dooley F, Kelly M, Struijk W, Taylor L, et al., Immune Thrombocytopenia - A Practical Guide for Nurses and Other Allied
Healthcare Professionals. 2011: European Group for Blood and Marrow Transplantation.
Bussel JB. Immune thrombocytopenia (ITP) in children: Clinical features and diagnosis. 2020 17/8/2020]; Available from: Up-to-date.com.
Calverley DC, Garland K, Haley KM, Recht M, Chapter 48: Thrombocytopenia Caused by Immunologic Platelet Destruction, in Wintrobe’s Clinical Hematology 40th ed. 2019, Washington University School of Medicine: Saint Louis, Missouri. p. pp. 3359-3434.
Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood advances. 2019. 3: pp. 3780-3817.
Kühne T, Buchanan GR, Zimmerman S, Michaels LA, Kohan R, Willi Berchtold, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. The Journal of Pediatrics. 2003. 143: pp. 605-608.
Zeller B, Rajantie J, Hedlund-Treutiger I, Tedgård U, Wesenberg F, Jonsson OG, et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatrica. 2005. 94: pp. 178-184.
Kühne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, Buchanan GR, et al. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet. 2001. 358: pp. 2122-2125.
Sutor AH, Harms A, Kaufmehl K. Acute Immune Thrombocytopenia (ITP) in Childhood: Retrospective and Prospective Survey in Germany. Seminars in thrombosis and hemostasis. 2001. 27: pp. 253-267.
Watts RG. Idiopathic Thrombocytopenic Purpura: A 10-Year Natural History Study at the Childrens Hospital of Alabama. Clinical Pediatrics. 2014. 43: pp. 691-702.
Donato H, Picón A, Martinez M, Rapetti MC, Rosso A, Gomez S, et al. Demographic Data, Natural History, and Prognostic Factors of Idiopathic Thrombocytopenic Purpura in Children: A Multicentered Study From Argentina. Pediatric Blood & Cancer. 2009. 52: pp. 491-496.
Bolton-Maggs PH , Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. The Lancet. 1997. 350: pp. 620-623.
Zeller B, Helgestad J, Hellebostad M, Kolmannskog S, Nystad T, Stensvold K, et al. Immune thrombocytopenic purpura in childhood in Norway: A prospective, population-based registration. Pediatric Hematology and Oncology. 2000. 17: pp. 551-558.
| Đã xuất bản | 24-01-2025 | |
| Toàn văn |
|
|
| Ngôn ngữ |
|
|
| Số tạp chí | Số 72 (2021) | |
| Phân mục | Nghiên cứu | |
| DOI | 10.38103/jcmhch.2021.72.10 | |
| Từ khóa | Keywords: Immune thrombocytopenia, children, clinical features, hematological features. |
công trình này được cấp phép theo Creative Commons Attribution-phi thương mại-NoDerivatives 4.0 License International .
Bản quyền (c) 2021 Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế